Invivyd

🔒New Haven biotech gets one-year notice that COVID therapy’s emergency authorization will end

Invivyd plans to seek full FDA approval for its COVID prevention treatment.

🔒New Haven-based biotech firm nets $117M from public offering

Invivyd Inc., a New Haven-based biotechnology company developing antibody-based treatments, recently announced it had raised a net $117.2 million from an underwritten public offering.

🔒New Haven biotech advances vaccine-alternative to prevent COVID

Invivyd Inc. said it has received federal approval to begin large-scale testing of a new drug designed to prevent COVID-19 infections.
Get our email newsletters

Stay up-to-date on the companies, people and issues that impact businesses in Hartford and beyond.

Sign Up Now
ADVERTISEMENT

Latest Stories

More Business News

Movers & Shakers

More Movers & Shakers | Submit an Announcement
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job

Upcoming Events

View Calendar
More Events | Submit an Event